BackOdonate Therapeutics Overview

Odonate Therapeutics Receivables

Track Odonate Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Odonate Therapeutics Receivables History

Loading

Odonate Therapeutics vs. peers: Receivables Comparison

Loading

Odonate Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Odonate Therapeutics (ODT) FAQ

Odonate Therapeutics (ODT) currently reports a receivables of $0 as of September 2021. In the prior-year period, the figure was $0. Use the charts on this page to explore Odonate Therapeutics's receivables history and peer comparisons.

Odonate Therapeutics's receivables changed from $0 to $0 (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Odonate Therapeutics reported $0 in receivables as of September 2021. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Odonate Therapeutics, and consider following ODT for alerts when major investors trade the stock.

Odonate Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ODT with unrelated industries.